Slóvakía - slóvakíska - myHealthbox

bayer ag - tekutý koncentrát miešateľný s vodou - ethephon 480 g/l

Slóvakía - slóvakíska - myHealthbox

bayer ag - suspenzný koncentrát - prothioconazole 175 g/l; trifloxystrobin 150 g/l

Evrópusambandið - slóvakíska - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - karcinóm, šquamózna bunka - antineoplastické činidlá - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Evrópusambandið - slóvakíska - EMA (European Medicines Agency)

bayer ag - darolutamide - prostatic neoplasms, kastrácia-odolný - endokrinná terapia - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bayer ag - moxifloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag - terbinafín - 26 - antimycotica (lokÁlne a celkovÉ)

Evrópusambandið - slóvakíska - EMA (European Medicines Agency)

takeda manufacturing austria ag - inhibítor c1 (ľudský) - angioedémy, dedičné - c1-inhibítora, plazma, benzínu, liekov používaných v dedičné angioedema - liečba aprevenciaatakov angioedému útoky u dospelých, dospievajúcich a detí (2 roky staré a vyššie) s hereditárnym angioedémom (hae). rutinné prevencia angioedema útoky u dospelých, dospievajúcich a detí (6 rokov a vyššie) s závažné a opakujúce útoky dedičných angioedema (hae), ktorí netolerujú alebo nedostatočne chránené ústne prevencia, liečba, alebo pacientov, ktorí sú nedostatočne liečená s opakované akútne ošetrenie.

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - kyselina ibandrónová - 87 - varia i

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - tadalafil - 83 - vasodilatantia

Slóvakía - slóvakíska - ŠÚKL (Štátny ústav pre kontrolu liečiv)

stada arzneimittel ag, nemecko - erlotinib - 44 - cytostatica